What is a clinical trial — and why should you participate?

Clinical trials at PVH test new devices, treatments, or procedures to improve care for people with vascular conditions like peripheral artery disease. Before a clinical trial starts, devices go through testing to check if they are safe, work well, and are compatible with the body — this careful process ensures only certain ideas move forward.

Clinical trials happen in different phases. They start with early feasibility trials, move to larger pivotal trials, and end with post-market trials. The time it takes to complete a trial can be different for each one, lasting from a few months to several years. It depends on how complex the condition is, the type of device being tested, and how long participants are monitored after treatment. Every step of a clinical trial is done with strict rules to protect participants and make sure the results are trustworthy and high quality.

Clinical trial phases

Early feasibility

Small trials are done to test the safety and basic function of a device in people for the first time.

Pivotal trial

Larger trials are done to confirm the device is safe and works well. These results are used to get approval from regulators.

Post-market trial

After approval, trials continue to track how the device performs in real-life situations to ensure it stays safe and effective over time.

Why join a clinical trial?

Patients who participate may get early access to new treatments and receive expert care and close monitoring. They also help researchers learn more, which improves care for others in the future. Every person who joins a trial in PVH plays an important role in advancing treatments for vascular conditions.

If you want to learn more about clinical trials, you can visit government databases like ClinicalTrials.gov.

Transparency in clinical trials

At Medtronic, being transparent means openly sharing information with patients, doctors, and the medical community. This helps build trust, encourage new ideas, and support better decisions to improve research and care for conditions affecting peripheral vascular health. Transparency is especially important in PVH for creating better treatments for complex vascular conditions and helping patients get better outcomes.

All applicable clinical trials are federally required to be registered on ClinicalTrials.gov. Medtronic values clinical trial transparency, and, to that end, believes in and complies with this requirement. ClinicalTrials.gov provides details about each trial, such as its purpose, how it’s designed, who can join, and its progress. After a trial is finished, Medtronic shares a summary of the results on this site — whether the outcomes are positive, negative, or unclear — so the public can learn from the findings.

An Institutional Review Board (IRB) or Ethics Committee (EC) plays an important role in ensuring transparency, safety, and ethics in clinical trials. These groups act as independent safeguards for patients and ensure research is done responsibly. The IRB/EC makes sure patients are clearly told about the risks, benefits, and what will happen during the trial before they agree to take part. They also monitor the trial while it’s going on to make sure ethical guidelines like the Declaration of Helsinki and Good Clinical Practice (GCP) are followed.

Medtronic also shares its research by publishing articles in scientific journals and presenting at medical conferences. By making clinical trial data easy to access and understand, Medtronic is working toward a future where research is more open and continues to be based on strong evidence.

Representation in clinical trials

Medtronic believes in creating equal access to life-changing solutions and striving to develop products and therapies that work for patients — no matter who or where they are. When clinical trials reflect the real variety of patients with a disease, the results are more accurate and helpful for everyone. This is why being a leader in increasing clinical trial diversity continues to be one of our top priorities.

FAQ

Expand All

PVH clinical trials at Medtronic follow strict safety rules and are carefully watched by ethics committees, government agencies, and experienced medical professionals. We always put patients first, making sure safety, honesty, and care are the main focus of every trial. While all medical research has some risks, these risks and the protections in place are explained clearly to participants before they join a trial.

Clinical trials usually start with a screening process to see if you qualify to join. If you’re eligible and decide to participate, you’ll learn all about the trial during an informed consent process. During the informed consent process, you will have the opportunity to ask your provider questions about the trial and review the risks and benefits; you are able to withdraw your consent at any time during the trial. As a participant, you might get investigational treatments and go to regular appointments for check-ups, tests, and assessments. After the treatment phase, there’s often a follow-up period where your health is still monitored. The number of visits and the timeline depend on the specific trial, but the research team will guide you through every step.

Each trial has certain requirements, often referred to as inclusion criteria. For PVH trials, this might include conditions like peripheral artery disease or other vascular health problems. Your doctor or the clinical trial team will check these requirements and help you decide if the trial is right for you.

Clinical trials follow strict rules to keep your personal and medical information private. Your data is stored securely and often de-identified before being used in the trial’s results. There are also laws that stop your information from being shared for anything unrelated to the trial. You can leave the trial at any time, and the research team will explain how your information will be handled before you join.

Talk to your doctor — they might know about local or specialized trials. You can also check Medtronic PVH’s list of clinical trials. Government websites like ClinicalTrials.gov let you search for trials based on your condition, location, or treatment options.